Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation.
- DOI
- 10.1155/2022/5983959
- Published
- 2022
- Container
- Evidence-based complementary and alternative medicine : eCAM
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1155/2022/5983959,
title = {Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation.},
author = {Wang Y and Hu J and Sun Y and Song B and Zhang Y and Lu Y and Ma H},
year = {2022},
journal = {Evidence-based complementary and alternative medicine : eCAM},
doi = {10.1155/2022/5983959},
url = {https://doi.org/10.1155/2022/5983959}
}RIS
TY - JOUR TI - Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation. AU - Wang Y AU - Hu J AU - Sun Y AU - Song B AU - Zhang Y AU - Lu Y AU - Ma H PY - 2022 JO - Evidence-based complementary and alternative medicine : eCAM DO - 10.1155/2022/5983959 UR - https://doi.org/10.1155/2022/5983959 ER -
APA
Y, W., J, H., Y, S., B, S., Y, Z., Y, L., & H, M. (2022). Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/5983959
Source records
- pubmed · retrieved 2026-09-25T04:20:23.415Z